Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma (Q34265995)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

main subject

hepatocellular carcinoma

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Shan-Shan Jiang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

De-Sheng Weng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Qi-Jing Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ke Pan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yong-Qiang Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jian-Jun Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jing-Jing Zhao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jia He

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Lin Lv

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Qiu-Zhong Pan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jian-Chuan Xia

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

27 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

Journal of Translational Medicine

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

20 February 2020

copyright license

start time

27 September 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Increased circulation of galectin-3 in cancer induces secretion of metastasis-promoting cytokines from blood vascular endothelium

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Galectin-3 regulates p21 stability in human prostate cancer cells.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Epigenetic regulation of galectin-3 expression by β1 integrins promotes cell adhesion and migration.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-catenin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

6 July 2018

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Diagnostic utility of galectin-3 in thyroid cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Tumor targeting and SPECT imaging properties of an (111)In-labeled galectin-3 binding peptide in prostate carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Tumor-associated galectin-3 modulates the function of tumor-reactive T cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Contributions of galectin-3 and -9 to epithelial cell adhesion analyzed by single cell force spectroscopy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Galectin-3 expression correlates with apoptosis of tumor-associated lymphocytes in human melanoma biopsies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Hepatocellular carcinoma: the need for progress.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

On the role of galectin-3 in cancer apoptosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Extracellular functions of galectin-3.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Epidemiology of primary liver cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Mortality by cause for eight regions of the world: Global Burden of Disease Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Galectins. Structure and function of a large family of animal lectins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179848

Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12967-014-0273-3

Claudin-1 as a promoter of EMT in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12967-014-0273-3

Identification of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12967-014-0273-3

Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12967-014-0273-3

Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12967-014-0273-3

Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12967-014-0273-3

Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12967-014-0273-3

Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas

1 reference

12 December 2020

CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions

1 reference

12 December 2020

Galectin-3 expression in colorectal cancer: relation to invasion and metastasis

1 reference

12 December 2020

Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer

1 reference

12 December 2020

The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells

1 reference

12 December 2020

10.1186/S12967-014-0273-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

PubMed publication ID

25260879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25260879%20AND%20SRC:MED&resulttype=core&format=json